BIOMAT Database Logo BIOMAT Database Logo

Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism. 1991

W S Oetting, and H Y Handoko, and M M Mentink, and A S Paller, and J G White, and R A King
Department of Medicine, University of Minnesota, Minneapolis 55455.

We have analyzed the tyrosinase coding region of three individuals having Type IA OCA within an extended family using genomic DNA amplification and dideoxy sequencing. Two of the affected individuals are dizygotic twins. All three have a common missense mutation at codon 81 (Pro----Leu) within exon I. The twins have a second missense mutation at codon 371 (Asn----Thr) within exon III and the third individual has a second missense mutation at codon 47 (Gly----Asp) within exon I. For each of these three individuals, the loss of enzyme function is the result of two different mutations, showing that they are compound heterozygotes of two mutant tyrosinase alleles.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014442 Monophenol Monooxygenase An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1. Dopa Oxidase,Phenoloxidase,Tyrosinase,Cresolase,Phenol Oxidase,Phenoloxidase A,Phenoloxidase B,Monooxygenase, Monophenol,Oxidase, Dopa,Oxidase, Phenol
D016115 Albinism, Oculocutaneous Heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. The two most common are the tyrosinase-positive and tyrosinase-negative types. Albinism, Tyrosinase-Negative,Albinism, Tyrosinase-Positive,Albinism, Yellow-Mutant,Oculocutaneous Albinism,Yellow Mutant Albinism,Albinism, Tyrosinase Negative,Albinism, Tyrosinase Positive,Albinism, Yellow Mutant,Mutant Albinism, Yellow,Mutant Albinisms, Yellow,Tyrosinase-Negative Albinism,Tyrosinase-Positive Albinism,Yellow-Mutant Albinism

Related Publications

W S Oetting, and H Y Handoko, and M M Mentink, and A S Paller, and J G White, and R A King
Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
January 1992, Pigment cell research,
W S Oetting, and H Y Handoko, and M M Mentink, and A S Paller, and J G White, and R A King
Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism.
February 1991, American journal of human genetics,
W S Oetting, and H Y Handoko, and M M Mentink, and A S Paller, and J G White, and R A King
Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.
November 1992, Human genetics,
W S Oetting, and H Y Handoko, and M M Mentink, and A S Paller, and J G White, and R A King
A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism.
May 1990, Proceedings of the National Academy of Sciences of the United States of America,
W S Oetting, and H Y Handoko, and M M Mentink, and A S Paller, and J G White, and R A King
A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism.
July 1991, Journal of medical genetics,
W S Oetting, and H Y Handoko, and M M Mentink, and A S Paller, and J G White, and R A King
Prenatal diagnosis of tyrosinase-negative oculocutaneous albinism.
September 1992, Lancet (London, England),
W S Oetting, and H Y Handoko, and M M Mentink, and A S Paller, and J G White, and R A King
Three different frameshift mutations of the tyrosinase gene in type IA oculocutaneous albinism.
July 1991, American journal of human genetics,
W S Oetting, and H Y Handoko, and M M Mentink, and A S Paller, and J G White, and R A King
Detection of mutations in the tyrosinase gene in a patient with type IA oculocutaneous albinism.
June 1990, The New England journal of medicine,
W S Oetting, and H Y Handoko, and M M Mentink, and A S Paller, and J G White, and R A King
Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism.
January 1997, Pigment cell research,
W S Oetting, and H Y Handoko, and M M Mentink, and A S Paller, and J G White, and R A King
Visual acuity development in tyrosinase negative oculocutaneous albinism.
February 1984, Documenta ophthalmologica. Advances in ophthalmology,
Copied contents to your clipboard!